20/20 Biolabs, Inc. (AIDX) › Cost of Revenue20/20 Biolabs, Inc. (AIDX) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2024: $1.39M2025: $1.44M$1.44M2024Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$1.44M+3.5%2024$1.39M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share